Biodesix, Inc.BDSXNASDAQ

Revenue (LTM)

$88M

+24.1% YoY

Net Income (LTM)

$-35M

+17.9% YoY

Free Cash Flow

$-24M

Revenue CAGR (5Y)

+14.2%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	55	38↓29.9%	49↑28.5%	71↑45.3%	88↑24.1%
Gross Profit	24	24↑0.3%	36↑50.0%	56↑54.5%	67↑19.5%
Operating Income	-41	-51↓23.6%	-41↑18.3%	-34↑16.6%	-28↑19.2%
Net Income	-43	-65↓51.6%	-52↑20.3%	-43↑17.7%	-35↑17.9%
EBITDA	-35	-52↓45.3%	-37↑28.0%	-29↑21.3%	-22↑25.1%
EPS Diluted	-31.60	-31.00↑1.9%	-12.80↑58.7%	-6.60↑48.4%	-4.67↑29.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	33	43↑31.7%	26↓39.0%	26↓0.1%	19↓27.7%
Total Current Assets	44	53↑22.3%	40↓25.6%	39↓0.5%	33↓17.6%
Total Assets	76	93↑22.1%	99↑6.7%	97↓1.9%	87↓10.0%
Total Current Liabilities	29	23↓21.1%	33↑46.3%	14↓57.2%	17↑21.8%
Total Liabilities	56	72↑28.3%	95↑30.7%	76↓19.2%	90↑17.8%
Total Equity	20	21↑4.5%	5↓77.8%	21↑355.8%	-2↓111.8%
Total Debt	10	32↑218.1%	61↑90.6%	62↑2.1%	73↑17.6%
Net Debt	-23	-11↑50.5%	34↑406.2%	36↑3.8%	54↑50.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-28	-45↓59.3%	-23↑49.1%	-49↓112.7%	-23↑52.2%
Capital Expenditure	-3	-4↓38.8%	-23↓552.6%	-3↑86.0%	-0↑92.0%
Free Cash Flow	-31	-49↓57.6%	-46↑5.3%	-52↓12.9%	-24↑54.6%
Stock-Based Comp	5	6↑20.6%	5↓9.9%	7↑23.5%	4↓37.6%
Net Change in Cash	-30	10↑135.2%	-17↓261.9%	-0↑99.8%	-7↓18507.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance